| Literature DB >> 15217290 |
Hiranthi Jayasuriya1, Kithsiri B Herath, John G Ondeyka, Jon D Polishook, Gerald F Bills, Anne W Dombrowski, Marty S Springer, Sal Siciliano, Lorraine Malkowitz, Manuel Sanchez, Ziqiang Guan, Suroojnauth Tiwari, Dennis W Stevenson, Robert P Borris, Sheo B Singh.
Abstract
Human CCR5 is a G-coupled receptor that binds to the envelope protein gp120 and CD4 and mediates the HIV-1 viral entry into the cells. The blockade of this binding by a small molecule receptor antagonist could lead to a new mode of action agent for HIV-1 and AIDS. Screening of natural product extracts led to the identification of anibamine (1), a novel pyridine quaternary alkaloid as a TFA salt, from Aniba sp.; ophiobolin C from fermentation extracts of fungi Mollisia sp.; and 19,20-epoxycytochalasin Q from Xylaria sp. Formation of the TFA salt of anibamine is plausibly an artifact of the isolation. The identity of the natural counterion is unknown. Anibamine.TFA competed for the binding of 125I-gp120 to human CCR5 with an IC50 of 1 microM. Ophiobolin C and 19,20-epoxycytochalasin Q exhibited binding IC50) values of 40 and 60 microM, respectively.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15217290 DOI： 10.1021/np049974l
Source DB: PubMed Journal: J Nat Prod ISSN： 0163-3864 Impact factor: 4.050